Last week, a woman with breast cancer sat across from me and asked whether she had caused it. She didn’t say it that way. She told me she had taken hormone therapy when she entered menopause, then asked, “The hormones caused this, didn’t they?” She was looking backward at a decision she had made and trying to understand whether she had harmed herself.
I told her it was more complicated.
A few days later, I read a study about hormone therapy and dementia. Researchers followed more than 180,000 postmenopausal women for an average of 13 years. Women who had used hormone therapy for at least a year had a lower risk of developing dementia. The association was strongest among women who started between ages 46 and 56.
In 2003, researchers from the Women’s Health Initiative Memory Study reported that women taking estrogen plus progestin had about twice the risk of probable dementia. It was a randomized trial. But the women in that trial were 65 or older. That detail got smaller somewhere between the medical journals and the doctors’ offices, smaller still by the time it reached how women understood their own bodies. The warning traveled farther than the population it actually studied.
Hormone therapy became something to fear. I watched it happen. Women became wary. Physicians became reluctant to prescribe it. A decision that should have turned on age, symptom severity, type of hormone, and individual risk became a simple rule: dangerous.
My patient’s question wasn’t really about dementia studies. Her cancer had forced her backward through her own medical history, and now that history was being reexamined through the lens of a terrible outcome. Medical warnings move out of journals into people’s lives. They attach to regret. They become the story people tell about their own choices.
The new study doesn’t erase the old one. Put them together and something becomes visible: one studied women 65 and older, the other found its strongest association with lower dementia risk among women starting between 46 and 56. The warning was built on a population that looks very different from the population now receiving it.
A third study adds to this. Researchers examining autopsied brains found less Alzheimer pathology among women who had used estrogen-only hormone therapy. We don’t know if this means anything — autopsy studies can’t prove what prevented anything. But neither can we keep treating a single finding from a 2003 trial of older women as though it applies equally to a 50-year-old having hot flashes every two hours, whose brain fog has made her work nearly impossible.
The question was never whether hormones are good or bad. It was which ones, for whom, at what age, for what.
If a woman sat across from me now considering hormone therapy, I would want to know what was happening in her life before we talked about treatment. Is she waking in hot flashes? Has her concentration fractured? Is anxiety moving through her day? What is her medical history and what does she carry into this decision? What does she want treatment to actually do?
These questions don’t become headlines. They’re closer to medicine.
My patient last week was frightened about cancer, not dementia. But underneath her question was what I hear whenever someone is trying to make sense of something terrible: Did I make the wrong choice? The woman in the 2003 trial was 65 years old. My patient made her decision at 50. But that warning didn’t stay in the journal. It moved out into the world and landed on every woman, at every age, in every stage of this transition, saying the same thing: don’t do this, it will damage you.
If you’re navigating menopause and trying to make sense of what’s changing and what actually deserves treatment, I wrote The Menopause Guide to help with exactly that — understanding the changes, sorting through your options, and preparing for a conversation with your clinician that’s grounded in what you actually need, not what you’re afraid of.
